Ultra Clean Holdings delivered the kind of quarter that rarely coincides with a stock cut in half. Non-GAAP earnings of $1.15 per share beat the $0.91 consensus by 21.1% and cleared the $0.95 Earnings Whisper number. Earnings grew 475.0% year over year. Revenue rose 48.8% to a record $759.0 million, 4.6% above the $725.45 million consensus and above the top of management's own $700-750 million guidance range. The central tension is that the shares entered the report down 51.4% since the open after the August release. That collapse coincided with an operating story that kept improving. Some of the explanation sits in the balance sheet, not the income statement.
The quality of the beat on the operating line is genuine. Non-GAAP gross margin expanded for a fourth straight quarter, reaching 17.3%, up from 16.7% in Q2 and 16.1% in Q4 2025. Non-GAAP operating margin jumped to 9.0% from 7.0% sequentially and 4.9% two quarters before that, as operating expenses fell to 8.3% of revenue from 9.7%. On a GAAP basis, UCT swung from a $10.9 million loss a year ago to $39.1 million in net income, or $0.85 per share. The GAAP result was helped by a far more normal 20.2% tax rate, versus 60.3% in Q2 when U.S. valuation allowances distorted the provision. The refinancing into $600 million of convertible notes also cut quarterly interest expense to $1.5 million from $9.9 a year ago. Products drove the surge, with revenue up from $445.0 million to $681.9 million year over year, though at a thinner 15.6% GAAP gross margin than Services' 28.8%.
The call reinforced the demand narrative. Management firmed its 2027 wafer-fab-equipment view to above $200 billion, narrowed from the prior $190-220 billion range, and described 2028 as "more or less booked." The new NPX initiative produced its first concrete tally: eight program wins across etch, ALD, PVD and lithography, with a similar number in qualification. UCT pulled its $4 billion capacity target forward to Q1 2027 from mid-2027. It outlined $80-100 million of incremental capex toward a $5 billion-plus run rate and reiterated a 20% gross-margin target at $4 billion. Fourth-quarter guidance calls for revenue of $800-860 million and non-GAAP EPS of $1.11-1.35. That outlook is in line with expectations rather than a blowout. The roughly 9.4% sequential growth implied at the midpoint is a step down from Q3's 18% pace.
Bears have legitimate ammunition, and most of it is about funding the growth. Operating cash flow was negative for a third straight quarter at -$42.3 million, bringing the nine-month burn to $116.7 million. Inventory has nearly doubled since year-end to $723.3 million, rising $93.4 million in Q3 alone. The call disclosed roughly 2.6 million shares sold through the at-the-market program for about $203 million, lifting the projected Q4 diluted share count to 48.9 million from 46.2 million. The released cash-flow statement shows only $34.0 million of ATM proceeds through September. That suggests much of the issuance came after quarter-end, a timing question investors will want clarified. The contrast with $40 million of buybacks earlier in the year is awkward. That dilution also explains why the Q4 EPS midpoint sits only modestly above Q3 despite higher revenue. Additional risks include:
- an MFC shortage expected to last one to two quarters, though management cited no missed shipments;
- top-two customer concentration rising to 61%;
- a warning that new capacity phases may temporarily pressure margins.
The market setup is more complicated than the surprise implies. Going into the report, shares sat at $46.71, 36.9% below the 200-day moving average of $74.06 and 52.7% below the $98.68 inter-earnings high set the day after the last report. They were just 6.3% above the October 22 low of $43.96. Investor sentiment slipped from 0.063 to 0.026, still marginally positive but closer to neutral. That is a modest cooling, not capitulation. The Earnings Whispers trend readings reflect the split: sequential growth and momentum are positive, while price and AVWAP trends remain negative.
The bottom line is that UCT's fundamentals are moving in the right direction on nearly every operating measure. Revenue is at a record, margins are climbing steadily, the industry outlook is firmer and capacity is arriving early. The market, however, has been pricing in the cost of that growth: persistent cash burn, a swelling inventory balance, concentrated customers and shareholder dilution. A quarter this strong strengthens the earnings case. Whether the stock can repair its damaged technical position likely depends on UCT showing that the growth can begin to fund itself.